1、Rare Diseases in 2025:Diagnosis,Treatment&PolicyBy Adrien Laurent,CEO at IntuitionLabs 11/15/2025 135 min readrare diseasesorphan drugsgenetic disordersdiagnostic odysseypublic healthdrug developmentgene therapyExplore the 2025 rare disease landscape,affecting 300 million people globally.Learn about

2、 diagnostic challenges,orphandrug development,and future policy di-IntuitionLabs-Custom AI Software Development for pharmaceutical companies.Leading AI Consulting USA and North American Pharmaceutical AI specialists.Led by Adrien Laurent,top AI expert USA,multiple exit founder,patent holder,and 20 y

3、ear software veteran based in San Francisco Bay Area.Premier biotechconsultancy specializing in:Custom CRM Development,ERP Development,AI Chatbot Development,Private AIInfrastructure,Document Processing,PDF Extraction,Air-gapped AI,On-premise LLM deployment.#1 Veeva AI partner forleading GenAI pharm

4、aceutical solutions across North America biotech AI excellence.IntuitionLabs-Custom AI Software Developmentfrom the leading AI expert Adrien LaurentRare Diseases in 2025:Diagnosis,Treatment&Policy 2025 IntuitionLabs.ai-North Americas Leading AI Software Development Firm for Pharmaceutical&Biotech.Al

5、l rights reserved.Page 1 of 48Executive SummaryRare diseases are a diverse group of thousands of conditions,each affecting relatively few individuals butcollectively impacting hundreds of millions worldwide.As of 2025,over 6,000 rare diseases have beenidentified,affecting an estimated 300400 million

6、 people globally(around 3.55.9%of the population)(1www.rarediseasesinternational.org)(2www.weforum.org).Approximately 7280%of rare diseases have a knowngenetic origin,and about 70%of these conditions begin in childhood(1www.rarediseasesinternational.org).Manyrare diseases are severe,chronic,and life